Publications, Pharmaceutical

Spray Dried Formulations for Nasal Applications – Challenges and Opportunities in Filling and Drug Delivery

Spray dried formulations, which are commonplace for inhaled drug delivery, offer considerable potential for nasal applications. This article describes an experimental study of the behavior of two spray dried formulations for nasal drug delivery, prepared with two different spray dryers under different operating conditions. The resulting formulations were physically characterized and assessed with respect to nasal deposition using a nasal cast (use courtesy of Aptar Pharma/DTF/Univ. of Tours); dose delivery was with an Aptar Pharma Unidose device. The filling performance of the formulations was also assessed. The spray dried formulations performed well in standard filling equipment and high dose deposition was observed in the olfactory region, a primary target for nose to brain drug delivery. Tests suggest minimal penetration to the lungs.

Download Publication
1 Sep 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

26 Feb 2024

Intranasal Delivery of Monoclonal Antibodies via Dry Powder

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
2 Feb 2024

Systemic Nasal Drug Delivery for CNS Diseases and Beyond

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Market Insights, Product Solutions

Read More
30 Jan 2024

Nanoparticle Formulation Strategies for Intranasal Drug Delivery

Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations

Read More
3 Jan 2024

Feasibility of Intranasal Delivery of Thin-Film Freeze-Dried Monoclonal Antibodies

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions

Read More
1 2 3 4 5 6 27
Back To Top